1. 2636 Outcomes and drug costs associated with alternate sunitinib dosing regimens in mRCC. (September 2015) Authors: Suo, A.; Iqbal, U.; Lim, J.; Lee, C.; Gesy, K.; Bryce, R.; Abbas, T.; Iqbal, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S525 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A determination of emergency department pre-triage times in patients not arriving by ambulance compared to widely used guideline recommendations – CORRIGENDUM. Issue 2 (27th February 2017) Authors: Betz, M.; Stempien, J.; Trivedi, S.; Bryce, R. Journal: CJEM Issue: Volume 19:Issue 2(2017:Mar.) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Continued efficacy of neratinib in patients with HER2-positive (HER2+) early-stage breast cancer: final overall survival (OS) analysis from the randomized phase 3 ExteNET trial. (April 2021) Authors: Martin, M.; Holmes, F.A.; Moy, B.; Mansi, J.; Gnant, M.; Buyse, M.; Barrios, C.; Bryce, R.; Wong, A.; Chan, A. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. E-Cigarettes and Pregnancy. Is a Closer Look Appropriate?. Issue 2 (June 2016) Authors: Bryce, R.; Robson, S.J. Journal: Obstetric anesthesia digest Issue: Volume 36:Issue 2(2016:Jun.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. KNOWLEDGE MANAGEMENT FOR LAND DEGRADATION MONITORING AND ASSESSMENT: AN ANALYSIS OF CONTEMPORARY THINKING. (17th June 2011) Authors: Reed, M. S.; Fazey, I.; Stringer, L. C.; Raymond, C. M.; Akhtar‐Schuster, M.; Begni, G.; Bigas, H.; Brehm, S.; Briggs, J.; Bryce, R.; Buckmaster, S.; Chanda, R.; Davies, J.; Diez, E.; Essahli, W.; Evely, A.; Geeson, N.; Hartmann, I.; Holden, J.; Hubacek, K. Journal: Land degradation & development Issue: Volume 24:Number 4(2013:Jul./Aug.) Page Start: 307 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Population effectiveness model of the consequences of recurrences following treatment with trastuzumab among women with HER2+ early stage breast cancer in the United States. (March 2019) Authors: Doan, Q.; Martin, M.; Lalla, D.; Halperin, M.; Barnett, B.; Bryce, R.; Danese, M.; Moy, B. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗